Inspire Announces Licensing Agreement- February 18, 2007 Inspire (NASDAQ:ISPH) is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with significant commercial potential and unmet medical needs. The research and development programs of Inspire are driven by extensive scientific experience in the therapeutic areas of ophthalmology and respiratoryallergy, and supported by expertise in the field of P2 receptors. Inspire is currently developing drug candidates for...http://gcoa.blogspot.com/2007/02/inspire-announces-licensing-agreement.html |